Evaluation of mutant frequencies at the hprt and the t-cell receptor loci in pediatric cancer patients before treatment

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 397, Issue 2, 1998, Pages 337-343

  Sawada, Machiko ^a   Kubota, Masaru ^a   Lin, Ying Wei ^a   Watanabe, Ken ichiro ^a   Koishi, Seiji ^a   Usami, Ikuya ^a   Akiyama, Yuichi ^a   Matsumura, Takafumi ^b   Furusho, Kenshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Child; Hodgkin's disease; hprt; Mutant frequency; Second malignancy; T cell antigen receptor

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MUTATION; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL;

EID: 0032472888     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00233-9     Document Type: Article

References (27)

1. Pui C.H., Behm F.G., Raimondi S.C., Dodge R.K., George S.L., Rivera G.K., Mirro J. Jr., Kalwinsky D.K., Dahl G.V., Murphy S.B., Crist W.M., Williams D.L. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N. Engl. J. Med. 321:1989;136-142.
2. Smith M.B., Xue H., Strong L., Takahashi H., Jaffe N., Ried H., Zietz H., Andrassy R.J. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J. Pediatr. Surg. 28:1993;1342-1349.
3. Cole J., Skopek T.R. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutation Res. 304:1994;33-105.
4. Dempsey J.L., Seshadri R.S., Morley A.A. Increased mutation frequency following treatment with cancer chemotherapy. Cancer Res. 45:1985;2873-2877.
5. Branda R.F., O'Neill J.P., Sullivan L.M., Albertini R.J. Factors influencing mutation at the hprt locus in T-lymphocytes: women treated for breast cancer. Cancer Res. 51:1991;6603-6607.
6. Caggana M., Liber H.L., Mauch P.M., Coleman C.N., Kelsey K.T. In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients. Environ. Mol. Mutagen. 18:1991;6-13.
7. Hirota H., Kubota M., Hashimoto H., Adachi S., Matsubara K., Kuwakado K., Akiyama Y., Tsutsui T., Mikawa H. Analysis of hprt gene mutation following anti-cancer treatment in pediatric patients with acute leukemia. Mutation Res. 319:1993;113-120.
8. Hirota H., Kubota M., Adachi S., Okuda A., Lin Y.W., Bessho R., Wakazono Y., Matsubara K., Kuwakado K., Akiyama Y., Tsutsui T. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation. Mutation Res. 315:1994;95-103.
9. Mott M.G., Boyse J., Hewitt M., Radford M. Do mutations at the glycophorin A locus in patients treated for childhood Hodgkin's disease predict secondary leukemia? Lancet. 343:1994;828-829.
10. Albertini R.J., Castle K.L., Borcherding W.R. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. USA. 79:1982;6617-6621.
11. Morley A.A., Trainor K.J., Seshadri R., Ryall R.G. Measurement of in vivo mutations in human lymphocytes. Nature. 302:1983;155-156.
12. + T cells. J. Exp. Med. 171:1990;1981-1999.
13. Heddle J.A., Swiger R.R. Risk estimation from somatic mutation assays. Mutation Res. 365:1996;107-117.
14. Henderson L., Cole H., Cole J., James S.E., Green M.H.L. Detection of somatic mutations in man: evaluation of the microtiter cloning assay for T-lymphocytes. Mutagenesis. 1:1986;195-200.
15. Cole J., Arlett C.F., Norris P.G., Stephens G., Waugh A.P.W., Beare D.M., Green M.H.L. Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients. Mutation Res. 273:1992;171-178.
16. Bigbee W.L., Langlois R.G., Swift M., Jensen R.H. Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am. J. Hum. Genet. 44:1989;402-408.
17. Langlois R.G., Bigbee W.L., Jensen R.H., German J. Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome. Proc. Natl. Acad. Sci. USA. 86:1989;670-674.
18. Friedberg E.C. Cockayne syndrome - a primary defect in DNA repair, transcription, both or neither? BioEssays. 18:1996;731-738.
19. Lin Y.W., Kubota M., Hirota H., Furusho K., Tomiwa K., Ochi J., Kasahara Y., Sasaki H., Ohta S. Somatic cell mutation frequency at the HPRT, T-cell antigen receptor and glycophorin A loci in Cockayne syndrome. Mutation Res. 337:1996;49-55.
20. Eshleman J.R., Lang E.Z., Bowerfind G.K., Parsons R., Vogelstein B., Willson J.K.V., Veigl M.L., Sedwick W.D., Markowitz S.D. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene. 10:1995;33-37.
21. Havre P.A., Yuan J., Hedrick L., Cho K.R., Glazer P.M. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res. 55:1995;4420-4424.
22. Hirota H., Kubota M., Hashimoto H., Akiyama Y., Mikawa H. Molecular analysis of HPRT gene mutation in T-lymphocytes of children after cancer chemotherapy. Proc. Am. Assoc. Cancer Res. 33:1992;394.
23. Finette B.A., Sullivan L.M., O'Neill J.P., Nicklas J.A., Vacek P.M., Albertini R.J. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutation Res. 308:1994;223-231.
24. Akiyama M., Kyoizumi S., Hirai Y., Kusunoki Y., Iwamoto K.S., Nakamura N. Mutation frequency in human blood cells increases with age. Mutation Res. 338:1995;141-149.
25. Albertini R.J., Gennet I.N., Lambert B., Thilly W.G., Vrieling H. Mutation at the hprt locus. Mutation Res. 216:1989;65-88.
26. Sala-Trepat M., Cole J., Green M.H.L., Rigaud O., Vilcoq J.R., Moustacchi E. Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients, III: measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis. 5:1990;593-598.
27. Bhatia S., Robison L.L., Oberlin O., Greenberg M., Bunin G., Fossati-Bellani F., Meadows A.T. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 334:1996;745-751.